The worldwide CAR T-cell therapy market is experiencing substantial growth, driven by rising demand for cutting-edge cancer treatment options. This accelerated expansion is fueled by factors such as the authorization of CAR T-cell therapies for diverse treatments, advancements in engineering technologies, and increasing research and development eff